- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Crisil Ratings continues Anupam Rasayan India Ltd.'s long-term rating at Crisil A+/Watch Developing for Rs 1620 Cr bank facilities & Rs 160 Cr NCDs, and short-term at Crisil A1/Watch Developing. The 'Watch Developing' outlook persists due to the proposed acquisition of Bliss GVS Pharma Ltd, expected to include Rs 300 Cr debt. Clarity on funding will resolve the watch.